TUYEN CHUNG: Open Payments
NPI 1942768205 · LANGHORNE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$758 in 35 payments from 9 companies in 2025. Trend: 2023 $276 · 2024 $1,191 · 2025 $758
Food & beverage: $758
| Company | Payments | Amount |
|---|---|---|
| Averitas Pharma Inc. | 6 | $292 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 11 | $183 |
| Collegium Pharmaceutical, Inc. | 11 | $150 |
| BIOTRONIK NRO, Inc. | 2 | $43 |
| Boston Scientific Corporation | 1 | $23 |
| Indivior Inc. | 1 | $20 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $19 |
| SCILEX PHARMACEUTICALS INC. | 1 | $15 |
| Forte Bio-Pharma LLC | 1 | $14 |
Products named: QUTENZA, RELISTOR, XTAMPZA, Prospera, WaveWriter Alpha Prime 16, SUBLOCADE, JOURNAVX, ZTLido.
Industry payments across PA — which companies pay providers there.
